請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30867
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳為堅(Wei J. Chen) | |
dc.contributor.author | Shu-Ting Huang | en |
dc.contributor.author | 黃淑婷 | zh_TW |
dc.date.accessioned | 2021-06-13T02:18:47Z | - |
dc.date.available | 2007-02-13 | |
dc.date.copyright | 2007-02-13 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-02-01 | |
dc.identifier.citation | 1. Saha S, Chant D, Welham J, McGrath J: A systematic review of the prevalence of schizophrenia.[see comment]. PLoS Medicine / Public Library of Science 2005; 2(5)
2. Crow TJ: The two-syndrome concept: origins and current status. Schizophrenia Bulletin 1985; 11(3):471-86 3. Walker E, Kestler L, Bollini A, Hochman KM: Schizophrenia: etiology and course. Annual Review of Psychology 2004; 55:401-30 4. Kendler KS, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, Shinkwin R, Easter SM, Webb BT, Zhang J, Walsh D, Straub RE: Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. American Journal of Psychiatry 1996; 153(12):1534-40 5. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, Housman DE, Kazazian HH, Antonarakis S, Pulver AE: Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nature Genetics 1998; 20(1):70-3 6. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, Read T, Murphy P, Blaveri E, McQuillin A, Petursson H, Curtis D: Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. American Journal of Human Genetics 2001; 68(3):661-73 7. Liu CM, Hwu HG, Fann CS, Lin CY, Liu YL, Ou-Yang WC, Lee SF: Linkage evidence of schizophrenia to loci near neuregulin 1 gene on chromosome 8p21 in Taiwanese families. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2005; 134(1):79-83 8. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K: Neuregulin 1 and susceptibility to schizophrenia. American Journal of Human Genetics 2002; 71(4):877-92 9. Harrison PJ, Law AJ: Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biological Psychiatry 2006; 60(2):132-40 10. Lewis DA, Hashimoto T, Volk DW: Cortical inhibitory neurons and schizophrenia. Nature Reviews Neuroscience 2005; 6(4):312-24 11. Goff DC, Coyle JT: The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. American Journal of Psychiatry 2001; 158(9):1367-77 12. Law A: Schizophrenia, IV: neuregulin-1 in the human brain. American Journal of Psychiatry 2003; 160(8) 13. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE: Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.[see comment]. Nature Medicine 2006; 12(7):824-8 14. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, Gunnarsdottir S, Walker N, Petursson H, Crombie C, Ingason A, Gulcher JR, Stefansson K, St Clair D: Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. American Journal of Human Genetics 2003; 72(1):83-7 15. Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, Zammit S, O'Donovan MC, Owen MJ: Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia.[see comment]. Molecular Psychiatry 2003; 8(5):485-7 16. Bakker SC, Hoogendoorn ML, Selten JP, Verduijn W, Pearson PL, Sinke RJ, Kahn RS: Neuregulin 1: genetic support for schizophrenia subtypes. Molecular Psychiatry 2004; 9(12):1061-3 17. Corvin AP, Morris DW, McGhee K, Schwaiger S, Scully P, Quinn J, Meagher D, Clair DS, Waddington JL, Gill M: Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus. Molecular Psychiatry 2004; 9(2):208-13 18. Hall D, Gogos JA, Karayiorgou M: The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes, Brain, & Behavior 2004; 3(4):240-8 19. Thiselton DL, Webb BT, Neale BM, Ribble RC, O'Neill FA, Walsh D, Riley BP, Kendler KS: No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF). Molecular Psychiatry 2004; 9(8):777-83 20. Petryshen TL, Middleton FA, Kirby A, Aldinger KA, Purcell S, Tahl AR, Morley CP, McGann L, Gentile KL, Rockwell GN, Medeiros HM, Carvalho C, Macedo A, Dourado A, Valente J, Ferreira CP, Patterson NJ, Azevedo MH, Daly MJ, Pato CN, Pato MT, Sklar P: Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Molecular Psychiatry 2005; 10(4):366-74 21. Lachman HM, Pedrosa E, Nolan KA, Glass M, Ye K, Saito T: Analysis of polymorphisms in AT-rich domains of neuregulin 1 gene in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2006; 141(1):102-9 22. Walss-Bass C, Liu W, Lew DF, Villegas R, Montero P, Dassori A, Leach RJ, Almasy L, Escamilla M, Raventos H: A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biological Psychiatry 2006; 60(6):548-53 23. Walss-Bass C, Raventos H, Montero AP, Armas R, Dassori A, Contreras S, Liu W, Medina R, Levinson DF, Pereira M, Leach RJ, Almasy L, Escamilla MA: Association analyses of the neuregulin 1 gene with schizophrenia and manic psychosis in a Hispanic population. Acta Psychiatrica Scandinavica 2006; 113(4):314-21 24. Yang JZ, Si TM, Ruan Y, Ling YS, Han YH, Wang XL, Zhou M, Zhang HY, Kong QM, Liu C, Zhang DR, Yu YQ, Liu SZ, Ju GZ, Shu L, Ma DL, Zhang D: Association study of neuregulin 1 gene with schizophrenia.[see comment]. Molecular Psychiatry 2003; 8(7):706-9 25. Hong CJ, Huo SJ, Liao DL, Lee K, Wu JY, Tsai SJ: Case-control and family-based association studies between the neuregulin 1 (Arg38Gln) polymorphism and schizophrenia. Neuroscience Letters 2004; 366(2):158-61 26. Iwata N, Suzuki T, Ikeda M, Kitajima T, Yamanouchi Y, Inada T, Ozaki N: No association with the neuregulin 1 haplotype to Japanese schizophrenia. Molecular Psychiatry 2004; 9(2):126-7 27. Li T, Stefansson H, Gudfinnsson E, Cai G, Liu X, Murray RM, Steinthorsdottir V, Januel D, Gudnadottir VG, Petursson H, Ingason A, Gulcher JR, Stefansson K, Collier DA: Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Molecular Psychiatry 2004; 9(7):698-704 28. Tang JX, Chen WY, He G, Zhou J, Gu NF, Feng GY, He L: Polymorphisms within 5' end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Molecular Psychiatry 2004; 9(1):11-2 29. Zhao X, Shi Y, Tang J, Tang R, Yu L, Gu N, Feng G, Zhu S, Liu H, Xing Y, Zhao S, Sang H, Guan Y, St Clair D, He L: A case control and family based association study of the neuregulin1 gene and schizophrenia. Journal of Medical Genetics 2004; 41(1):31-4 30. Fukui N, Muratake T, Kaneko N, Amagane H, Someya T: Supportive evidence for neuregulin 1 as a susceptibility gene for schizophrenia in a Japanese population. Neuroscience Letters 2006; 396(2):117-20 31. Kim JW, Lee YS, Cho EY, Jang YL, Park DY, Choi KS, Jeun HO, Cho SH, Jang SY, Hong KS: Linkage and association of schizophrenia with genetic variations in the locus of neuregulin 1 in Korean population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2006; 141(3):281-6 32. Duan J, Martinez M, Sanders AR, Hou C, Krasner AJ, Schwartz DB, Gejman PV: Neuregulin 1 (NRG1 ) and schizophrenia: analysis of a US family sample and the evidence in the balance. Psychological Medicine 2005; 35(11):1599-610 33. Cardon LR, Palmer LJ: Population stratification and spurious allelic association. Lancet 2003; 361(9357):598-604 34. Evangelou E, Trikalinos TA, Salanti G, Ioannidis JP: Family-based versus unrelated case-control designs for genetic associations. PLoS Genetics 2006; 2(8) 35. Roy MA, Crowe RR: Validity of the familial and sporadic subtypes of schizophrenia. American Journal of Psychiatry 1994; 151(6):805-14 36. Lewis SW, Reveley AM, Reveley MA, Chitkara B, Murray RM: The familial/sporadic distinction as a strategy in schizophrenia research. Br J Psychiatry 1987; 151:306-13 37. Tsuang HC, Lin SH, Liu SK, Hsieh MH, Hwang TJ, Liu CM, Hwu HG, Chen WJ: More severe sustained attention deficits in nonpsychotic siblings of multiplex schizophrenia families than in those of simplex ones. Schizophr Res 2006; 87(1-3):172-80 38. Hall J, Whalley HC, Job DE, Baig BJ, McIntosh AM, Evans KL, Thomson PA, Porteous DJ, Cunningham-Owens DG, Johnstone EC, Lawrie SM: A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci 2006; 9(12):1477-8 39. Lin HF, Liu YL, Liu CM, Hung SI, Hwu HG, Chen WJ: Neuregulin 1 gene and variations in perceptual aberration of schizotypal personality in adolescents. Psychological Medicine 2005; 35(11):1589-98 40. Nurnberger JI, Jr., Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T: Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Archives of General Psychiatry 1994; 51(11):849-59 41. Chen WJ, Liu SK, Chang CJ, Lien YJ, Chang YH, Hwu HG: Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry 1998; 155(9):1214-20 42. Andreasen NC: The Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa City, IA. 1984 43. Hwu HG, Faraone SV, Liu CM, Chen WJ, Liu SK, Shieh MH, Hwang TJ, Tsuang MM, OuYang WC, Chen CY, Chen CC, Lin JJ, Chou FH, Chueh CM, Liu WM, Hall MH, Tsuang MT: Taiwan schizophrenia linkage study: the field study. Am J Med Genet B Neuropsychiatr Genet 2005; 134(1):30-6 44. O'Connell JR, Weeks DE: PedCheck: a program for identification of genotype incompatibilities in linkage analysis. American Journal of Human Genetics 1998; 63(1):259-66 45. Terwilliger JD, Ott J: Handbook of Human Genetic Linkage, in Baltimore: John Hopkins University Press., 1994 46. Liu K, Muse SV: PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 2005; 21(9):2128-9 47. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21(2):263-5 48. Hedrick PW: Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117(2):331-41 49. Laird NM, Horvath S, Xu X: Implementing a unified approach to family-based tests of association. Genetic Epidemiology 2000; 19(1) 50. Stefansson H, Steinthorsdottir V, Thorgeirsson TE, Gulcher JR, Stefansson K: Neuregulin 1 and schizophrenia. Annals of Medicine 2004; 36(1):62-71 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30867 | - |
dc.description.abstract | 目的:探討Neuregulin 1基因(NRG1)與精神分裂症家庭中不同的遺傳負荷之間的關係;同時利用家族關聯性分析去探究NRG1基因是否特別與精神分裂症之活性症狀有關。
方法:此研究的樣本可分為兩組:162個單發家庭(包含162個精神分裂症病患與355個一等親家屬)與42個多發家庭(包含83個精神分裂症病患與86個一等親家屬),所有參加研究的個案均由受過訓練訪員進行遺傳診斷問卷(DIGS)的訪談與抽血。在遺傳診斷問卷中,利用活性症狀量表(SAPS)來評估精神症狀,另外,利用MALDI-TOF質譜分析法或ABI7900來進行NRG1上的六個單一核苷酸多形性(SNP)的鑑定,並採用FBAT軟體來進行家族資料之單一基因座與半形關聯性分析。 結果:在半形分析部分,發現rs3924999-rs2954041雙基因半形與SNP8NRG243177-rs3924999-rs2954041三基因半形僅在單發家庭樣本中呈現較不傳遞的現象。另外,在依活性症狀分層後,相似的結果也可以在妄想症狀的單發家庭中看到,在任一妄想或幻覺症狀方面,也可以看到此關係。 結論: NRG1與精神分裂症的關聯性特別在有妄想症狀和有無併發幻覺症狀之病患的單發家庭中發現。我們推論NRG1在較易受環境影響之精神分裂症偶發家庭中扮演著重要的角色,並導致妄想症狀的發展。 | zh_TW |
dc.description.abstract | Objective. To examine the association between Neuregulin 1(NRG1) gene and schizophrenia in families of different genetic loading of schizophrenia and whether the association of the NRG1 gene is particularly with the positive symptoms of schizophrenia by means of family-based association analyses.
Methods. The subjects were from two different groups: 162 simplex families (162 schizophrenic probands and 355 of their first-degree relatives) and 42 multiplex families (83 schizophrenic probands and 86 of their first-degree relatives). All participants were interviewed by trained research assistants who used the Diagnostic Interview for Genetic Studies (DIGS), and drawn for peripheral blood. The DIGS also assessed psychopathological dimensions with the Scales for the Assessment of Positive Symptoms (SAPS). Six SNPs of the NRG1 gene were genotyped and FBAT program was used to perform single-locus and haplotype association analyses in family-based study Results. The two-locus rs3924999-rs2954041 haplotype and the three-locus SNP8NRG243177-rs3924999-rs2954041 haplotype of NRG1were found to have a decreased transmission in the simplex families only, not in the multiplex ones. After stratification by positive symptoms of schizophrenia, similar results were found only for the simplex families of schizophrenia patients with delusion as well as for those with delusion or hallucination. Conclusions. The association of NRG1 gene with schizophrenia is mainly limited to patients from simplex families having delusion with or without hallucination. We concluded that NRG1 gene may play a vital role in the sporadic form of schizophrenia that is more vulnerable to environmental influences and leads to the development of delusion. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T02:18:47Z (GMT). No. of bitstreams: 1 ntu-96-R93842015-1.pdf: 616306 bytes, checksum: 8a61d2af93d6cd9ce2436fa7c4a3eb29 (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | Acknowledgment I
Abstract (in Chinese) II Abstract III Content V List of tables and figures VI Introduction 1 Methods and material Subjects 4 Measurements 4 DIGS (Diagnostic Interview for Genetic Studies) 4 SAPS (Assessment of Positive Symptoms) 5 SNP Genotyping 5 Statistical analyses 6 Results 8 Discussion 12 References 37 Appendices I. Assessment of Positive Symptoms (SAPS) (in Chinese) 42 | |
dc.language.iso | en | |
dc.title | Neuregulin 1基因與精神分裂症之家族關聯研究:
遺傳負荷與精神病性症狀之影響 | zh_TW |
dc.title | A Family-Based Association Study of Neuregulin 1 Gene and Schizophrenia: Influence of Genetic Loading and Psychotic Symptoms | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李文宗,胡海國,蕭朱杏 | |
dc.subject.keyword | 家族關聯性,Neuregulin 1,精神分裂症,遺傳負荷,精神病性症狀,妄想,幻覺, | zh_TW |
dc.subject.keyword | family-based association,Neuregulin 1,schizophrenia,genetic loading,psychotic symptoms,delusion,hallucination, | en |
dc.relation.page | 44 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-02-01 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 601.86 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。